EPA-Approved SARS-CoV-2 Disinfectants
6 rows where "Date_on_List_N" is on date 2021-10-26 and Formulation_type contains "Dilutable"
json
Export this Data | Chart Risk Level by Product
Clear Chart
Add More Filters: Active_ingredient, Surface_type, Contact_time, Why_on_List_N,
ID ▼
|
EPA_reg_num
|
Risk_level
|
Active_ingredient
|
Product_name
|
Company
|
Use_site
|
Surface_type
|
Contact_time
|
Formulation_type
|
Follow_directions_for_this_virus
|
Date_on_List_N
|
Why_on_List_N
|
1270 |
71355-1 |
Increased Risk |
Quaternary ammonium; Glutaraldehyde |
Virocid |
CID Lines NV |
Institutional |
Hard Nonporous (HN) |
1.0 minutes |
Dilutable |
SARS-CoV-2 |
2021-10-26 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1383 |
10324-63 |
Increased Risk |
Quaternary ammonium |
Maquat 10 |
Mason Chemical Company |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
2.0 minutes |
Dilutable |
SARS-CoV-2 |
2021-10-26 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1388 |
10324-94 |
Increased Risk |
Quaternary ammonium |
Maquat 20-M |
Mason Chemical Company |
Healthcare; Institutional; Residential |
Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) |
2.0 minutes |
Dilutable |
SARS-CoV-2 |
2021-10-26 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1419 |
1677-250 |
Increased Risk |
Hydrogen peroxide; Peroxyoctanoic acid; Peroxyacetic acid (Peracetic acid) |
Synergex |
Ecolab Inc |
Institutional |
Hard Nonporous (HN) |
1.5 minutes |
Dilutable |
SARS-CoV-2 |
2021-10-26 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
2200 |
1677-246 |
Safer |
Capric acid |
73 Disinfecting Acid Bathroom Cleaner |
Ecolab Inc |
Healthcare; Institutional |
Hard Nonporous (HN) |
2.0 minutes |
Dilutable |
SARS-CoV-2 |
2021-10-26 |
Tested against SARS-CoV-2 (COVID-19) |
2202 |
1677-198 |
Increased Risk |
Quaternary ammonium |
Multi-Quat |
Ecolab Inc |
Institutional |
Hard Nonporous (HN) |
10.0 minutes |
Dilutable |
SARS-CoV-2 |
2021-10-26 |
Tested against SARS-CoV-2 (COVID-19) |